Considerations in the Use of Cerebrospinal Fluid Pharmacokinetics to Predict Brain Target Concentrations in the Clinical Setting

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Clinical Pharmacokinetics

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.2165/00003088-200241100-00001PMID 12162757
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ultrastructural aspects of the choroid plexus epithelium as revealed by the rapid-freezing and deep-etching techniques

  2004cited by this paper
• Neuroblastoma metastatic to the central nervous system

  2001cited by this paper
• Regulation of Blood—Brain Barrier Permeability

  2001cited by this paper
• Brain drug delivery, drug metabolism, and multidrug resistance at the choroid plexus

  2001cited by this paper
• Increased blood–brain barrier permeability of morphine in a patient with severe brain lesions as determined by microdialysis

  2001cited by this paper
• [Measurement of CSF flow in the spinal canal using MRI with an optimized MRI protocol: experimental and clinical studies].

  2001cited by this paper
• MR-tomographische Liquorflussmessungen am Spinalkanal mit einem optimierten MRT-Protokoll: Experimentelle und klinische Untersuchungen*

  2001cited by this paper
• Organic anion transport across the choroid plexus

  2001cited by this paper
• The use of microdialysis in CNS drug delivery studies. Pharmacokinetic perspectives and results with analgesics and antiepileptics.

  2000cited by this paper
• Microdialysis in the study of drug transporters in the CNS.

  2000cited by this paper
• Homeostatic role of the active transport in elimination of [3H]benzylpenicillin out of the cerebrospinal fluid system.

  2000cited by this paper
• Methotrexate distribution within the subarachnoid space after intraventricular and intravenous administration

  2000cited by this paper
• Penetration of Amitriptyline, but Not of Fluoxetine, into Brain is Enhanced in Mice with Blood-Brain Barrier Deficiency Due to Mdr1a P-Glycoprotein Gene Disruption

  2000cited by this paper
• Microdialysis in clinical drug delivery studies.

  2000cited by this paper
• Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier.

  2000cited by this paper
• Vascular Microenvironment in Gliomas

  2000cited by this paper
• Comparison of serum, cerebrospinal fluid and brain extracellular fluid pharmacokinetics of lamotrigine

  2000cited by this paper
• Brain and CSF entry of the novel nonnucleoside reverse transcriptase inhibitor, GW420867X

  2000cited by this paper
• Multiple actions of steroid hormones--a focus on rapid, nongenomic effects.

  2000cited by this paper
• In vitro and in vivo investigations on fluoroquinolones; effects of the P-glycoprotein efflux transporter on brain distribution of sparfloxacin.

  2000cited by this paper
• Magnetisation transfer imaging in multiple sclerosis.

  2000cited by this paper
• The role of probenecid-sensitive organic acid transport in the pharmacokinetics of N-methyl-D-aspartate receptor antagonists acting at the glycine(B)-site: microdialysis and maximum electroshock seizures studies.

  1999cited by this paper
• The role of P‐glycoprotein in blood‐brain barrier transport of morphine: transcortical microdialysis studies in mdr1a (−/−) and mdr1a (+/+) mice

  1999cited by this paper
• The cell biology of the blood-brain barrier.

  1999cited by this paper
• Investigation of distribution, transport and uptake of anti-HIV drugs to the central nervous system.

  1999cited by this paper
• Drug-protein binding and blood-brain barrier permeability.

  1999cited by this paper
• Pharmacologic Considerations for Therapeutic Success with Antiretroviral Agents

  1999cited by this paper
• Interactions between macrophages and brain microvascular endothelial cells: role in pathogenesis of HIV-1 infection and blood - brain barrier function.

  1999cited by this paper
• Transepithelial transport of organic anions across the choroid plexus: possible involvement of organic anion transporter and multidrug resistance-associated protein.

  1999cited by this paper
• Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier.

  1999cited by this paper
• Physiology and pathology of the blood-brain barrier: implications for microbial pathogenesis, drug delivery and neurodegenerative disorders.

  1999cited by this paper
• Carrier-mediated or specialized transport of drugs across the blood-brain barrier.

  1999cited by this paper
• Introduction to the Blood–Brain Barrier: Brain microvasculature in multiple sclerosis

  1998cited by this paper
• Ependymal development, proliferation, and functions: A review

  1998cited by this paper
• BBB Transport and P-glycoprotein Functionality Using MDR1A (-/-) and Wild-Type Mice. Total Brain Versus Microdialysis Concentration Profiles of Rhodamine-123

  1998cited by this paper
• Pharmacokinetics of Anticancer Drugs in Cerebrospinal Fluid

  1998cited by this paper
• Intracellular Phosphorylation of Zidovudine (ZDV) and Other Nucleoside Reverse Transcriptase Inhibitors (RTI) Used for Human Immunodeficiency Virus (HIV) Infection

  1998cited by this paper
• Introduction to the Blood–Brain Barrier: HIV infection and the blood–brain barrier

  1998cited by this paper
• Introduction to the Blood–Brain Barrier: Cerebral malaria and the brain microvasculature

  1998cited by this paper
• Introduction to the Blood–Brain Barrier: The blood-CSF barrier and the choroid plexus

  1998cited by this paper
• Cerebrospinal fluid production is normal in Down syndrome.

  1998cited by this paper
• The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors.

  1998cited by this paper
• Effect of the Mdr1a P-glycoprotein gene disruption on the tissue distribution of SDZ PSC 833, a multidrug resistance-reversing agent, in mice.

  1998cited by this paper
• Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice.

  1998cited by this paper
• A general pattern for substrate recognition by P-glycoprotein.

  1998cited by this paper
• Introduction to the Blood–Brain Barrier: The pathophysiology of blood–brain barrier dysfunction due to traumatic brain injury

  1998cited by this paper
• Introduction to the Blood–Brain Barrier: The blood-brain barrier in brain tumours

  1998cited by this paper
• Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of synthetic opioids in the rat: correlation with the interaction at the mu-opioid receptor.

  1998cited by this paper
• Central nervous side effects after lumbar puncture. A review of the possible pathogenesis of the syndrome of postdural puncture headache and associated symptoms.

  1997cited by this paper
• Quantitative structure-activity relationship of multidrug resistance reversal agents.

  1997cited by this paper
• Kinetic evidence for active efflux transport across the blood-brain barrier of quinolone antibiotics.

  1997cited by this paper
• Quantitative evaluation of brain distribution and blood-brain barrier efflux transport of probenecid in rats by microdialysis: possible involvement of the monocarboxylic acid transport system.

  1997cited by this paper
• The entry of antiviral and antiretroviral drugs into the central nervous system.

  1997cited by this paper
• Blood-brain barrier permeability during the development of experimental bacterial meningitis in the rat.

  1997cited by this paper
• Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833.

  1997cited by this paper
• Effect of plasma protein binding on in vivo activity and brain penetration of glycine/NMDA receptor antagonists.

  1997cited by this paper
• Drug Equilibration Across the Blood—Brain Barrier-Pharmacokinetic Considerations Based on the Microdialysis Method

  1997cited by this paper
• Effects of probenecid on brain-cerebrospinal fluid-blood distribution kinetics of E-Delta 2-valproic acid in rabbits.

  1997cited by this paper
• The choroid plexus epithelium is the site of the organic anion transport protein in the brain.

  1997cited by this paper
• The blood-brain barrier in neuroinflammatory diseases.

  1997cited by this paper
• Blood-to-Brain Transfer of Various Oxicams: Effects of Plasma Binding on Their Brain Delivery

  1997cited by this paper
• Doxepin and its metabolites in plasma and cerebrospinal fluid in depressed patients

  1997cited by this paper
• In Vivo Evidence for Carrier-Mediated Efflux Transport of 3 (cid:57) -Azido-3 (cid:57) -Deoxythymidine and 2 (cid:57) ,3 (cid:57) -Dideoxyinosine Across the Blood-Brain Barrier via a Probenecid-Sensitive Transport System 1

  1997cited by this paper
• Methodological considerations of intracerebral microdialysis in pharmacokinetic studies on drug transport across the blood-brain barrier.

  1997cited by this paper
• Central nervous side effects after lumbar puncture. A review of the possible pathogenesis of the syndrome of postdural puncture headache and associated symptoms.

  1997cited by this paper
• Role of efflux transport across the blood-brain barrier and blood-cerebrospinal fluid barrier on the disposition of xenobiotics in the central nervous system☆

  1997cited by this paper
• Pharmacokinetic profile of SDZ EAA 494 in blood, brain and CSF using microdialysis

  1997cited by this paper
• In vivo evidence for carrier-mediated efflux transport of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine across the blood-brain barrier via a probenecid-sensitive transport system.

  1997cited by this paper
• P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs.

  1996cited by this paper
• The Simultaneous Estimation of the Influx and Efflux Blood-Brain Barrier Permeabilities of Gabapentin Using a Microdialysis-Pharmacokinetic Approach

  1996cited by this paper
• Diffusion of 3-quaternary ammonium cephem antibiotics into cerebrospinal fluid of patients with bacterial meningitis.

  1996cited by this paper
• Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump.

  1996cited by this paper
• Physiology of the CSF and Blood-Brain Barriers

  1996cited by this paper
• The ependyma: A protective barrier between brain and cerebrospinal fluid

  1995cited by this paper
• Application of intracerebral microdialysis to study regional distribution kinetics of drugs in rat brain

  1995cited by this paper
• Transport of the Nucleoside, Thymidine, in the Central Nervous System: The Blood-Cerebrospinal Fluid and Blood-Brain Barriers

  1995cited by this paper
• Pharmacokinetic study of trimethadione and its metabolite in blood, liver and brain by microdialysis in conscious, unrestrained rats.

  1995cited by this paper
• The ependyma: A protective barrier between brain and cerebrospinal fluid

  1995cited by this paper
• The spinal loop dialysis catheter: characterization of use in the unanesthetized rat.

  1995cited by this paper
• Cerebrospinal fluid pharmacokinetics and penetration of continuous infusion topotecan in children with central nervous system tumors

  1995cited by this paper
• The Use of Intracerebral Microdialysis for the Determination of Pharmacokinetic Profiles of Anticancer Drugs in Tumor-Bearing Rat Brain

  1995cited by this paper
• Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.

  1995cited by this paper
• Pharmacokinetics of lamivudine and BCH-189 in plasma and cerebrospinal fluid of nonhuman primates

  1995cited by this paper
• The Dependency of Influx Across the Blood-Brain Barrier on Blood Flow and the Apparent Flow-Independence of Glucose Influx During Stress

  1995cited by this paper
• Antiepileptic drug pharmacokinetics and neuropharmacokinetics in individual rats by repetitive withdrawal of blood and cerebrospinal fluid: phenytoin.

  1994cited by this paper
• Kinetics of active efflux via choroid plexus of beta-lactam antibiotics from the CSF into the circulation.

  1994cited by this paper
• Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs.

  1994cited by this paper
• Investigation of the Distribution of EAB 515 to Cortical ECF and CSF in Freely Moving Rats Utilizing Microdialysis

  1994cited by this paper
• Enhanced expression by the brain matrix of P-glycoprotein in brain capillary endothelial cells.

  1994cited by this paper
• Prediction of brain delivery of ofloxacin, a new quinolone, in the human from animal data

  1994cited by this paper
• Localization of Drug‐Metabolizing Enzyme Activities to Blood‐Brain Interfaces and Circumventricular Organs

  1994cited by this paper
• The pathophysiology of pneumococcal meningitis.

  1994cited by this paper
• Report of a meeting: molecular basis of cancer therapy.

  1994cited by this paper
• Critical factors of intracerebral microdialysis as a technique to determine the pharmacokinetics of drugs in rat brain.

  1994cited by this paper
• Glutathione S-transferase isoenzymes in rat brain neurons and glia

  1993cited by this paper
• Distributional transport kinetics of zidovudine between plasma and brain extracellular fluid/cerebrospinal fluid in the rabbit: investigation of the inhibitory effect of probenecid utilizing microdialysis.

  1993cited by this paper
• Synthesis of carbon-11 labeled iodinated cocaine derivatives and their distribution in baboon brain measured using positron emission tomography.

  1992cited by this paper
• Electroencephalogram Effect Measures and Relationships Between Pharmacokinetics and Pharmacodynamics of Centrally Acting Drugs

  1992cited by this paper
• Blood‐Brain Barrier Penetration of Felbamate

  1992cited by this paper
• 19F nuclear magnetic resonance spectroscopy of neuroleptics: the first in vivo pharmacokinetics of trifluoperazine in the rat brain and the first in vivo spectrum of fluphenazine in the human brain.

  1991cited by this paper

• Antibiotic susceptibility of Gram-negative bacteria in cerebrospinal fluid compared to Mueller-Hinton broth and artificial cerebrospinal fluid.

  2026cites this paper
• Pharmacokinetics as a Biomarker

  2026cites this paper
• Assessing central nervous system drug delivery

  2025cites this paper
• Distribution of acyclovir in central nervous system compartments: a porcine pharmacokinetic model

  2025cites this paper
• Distribution of ganciclovir in the porcine central nervous system

  2025cites this paper
• Transporter Expressions as Part of Required Scaling Factor to Support In vitro In vivo Extrapolation for Blood-Brain Barrier Drug Permeability.

  2025cites this paper
• Exploring neuropharmacokinetics: mechanisms, models, and clinical implications

  2025cites this paper
• Pro-neurogenic potential of blood cells cultured in autologous plasma

  2025cites this paper
• The Impact of P‐Glycoprotein on CNS Drug Efflux and Variability in Response

  2025cites this paper
• Continuous evaluation of single-dose moxifloxacin concentrations in brain extracellular fluid, cerebrospinal fluid, and plasma: a novel porcine model.

  2024cites this paper
• Increased Antibiotic Susceptibility of Gram-Positive Bacteria in Cerebrospinal Fluid Compared to Broth

  2024cites this paper
• An intracerebral microdialysis study to determine the neuropharmacokinetics of eribulin in patients with metastatic or primary brain tumors

  2024cites this paper
• Polyinosinic/Polycytidylic Lipid Nanoparticles Enhance Immune Cell Infiltration and Improve Survival in the Glioblastoma Mouse Model

  2024cites this paper
• Active CNS delivery of oxycodone in healthy and endotoxemic pigs

  2024cites this paper
• Evaluation of cefuroxime concentration in the intrathecal and extrathecal compartments of the lumbar spine—an experimental study in pigs

  2023cites this paper
• The Upper Nasal Space: Option for Systemic Drug Delivery, Mucosal Vaccines and “Nose-to-Brain”

  2023cites this paper
• Prediction of ROS1 and TRKA/B/C occupancy in plasma and cerebrospinal fluid for entrectinib alone and in DDIs using physiologically based pharmacokinetic (PBPK) modeling approach

  2023cites this paper
• Rifampicin and protein concentrations in paired spinal versus ventricular cerebrospinal fluid samples of children with tuberculous meningitis

  2023cites this paper
• Prediction of trough concentration and ALK occupancy in plasma and cerebrospinal fluid using physiologically based pharmacokinetic modeling of crizotinib, alectinib, and lorlatinib

  2023cites this paper
• Polymer nanocarriers for targeted local delivery of agents in treating brain tumors

  2022cites this paper
• Design and Measurement of Drug Tissue Concentration Asymmetry and Tissue Exposure-Effect (Tissue PK-PD) Evaluation.

  2022cites this paper
• Role of Tissue Hydraulic Permeability in Convection-Enhanced Delivery of Nanoparticle-Encapsulated Chemotherapy Drugs to Brain Tumour

  2022cites this paper
• The choroid plexus: a missing link in our understanding of brain development and function.

  2022cites this paper
• Natural Blockers of PD-1/PD-L1 Interaction for the Immunotherapy of Triple-Negative Breast Cancer-Brain Metastasis

  2022cites this paper
• Zinc(II) complexes bearing N,N,S ligands: Synthesis, crystal structure, spectroscopic analysis, molecular docking and biological investigations about its antifungal activity.

  2022cites this paper
• A Historical Review of Brain Drug Delivery

  2022cites this paper
• Physiologically Based Pharmacokinetic and Pharmacodynamic Modeling of Diazepam: Unbound Interstitial Brain Concentrations Correspond to Clinical End Points

  2022cites this paper
• In Vivo Studies of Drug BBB Transport: Translational Challenges and the Role of Brain Imaging.

  2021cites this paper
• Understanding Drug Delivery to the Brain Using Liposome-Based Strategies: Studies that Provide Mechanistic Insights Are Essential

  2021cites this paper
• ADMET tools: Prediction and assessment of chemical ADMET properties of NCEs

  2021cites this paper
• Harnessing Cerebrospinal Fluid Circulation for Drug Delivery to Brain Tissues.

  2021cites this paper
• Physiologically Based Pharmacokinetic Modeling of Central Nervous System Pharmacokinetics of CDK4/6 Inhibitors to Guide Selection of Drug and Dosing Regimen for Brain Cancer Treatment

  2020cites this paper
• Pharmacokinetic and Pharmacodynamic Considerations

  2020cites this paper
• Investigation of MDR1-overexpressing cell lines to derive a quantitative prediction approach for brain disposition using in vitro efflux activities.

  2020cites this paper
• Cerebral Microdialysis as a Tool for Assessing the Delivery of Chemotherapy in Brain Tumor Patients.

  2020cites this paper
• Biological barriers, and the influence of protein binding on the passage of drugs across them

  2020cites this paper
• Regorafenib CSF Penetration, Efficacy, and MRI Patterns in Recurrent Malignant Glioma Patients

  2019cites this paper
• Application of the relationship between pharmacokinetics and pharmacodynamics in drug development and therapeutic equivalence: a PEARRL review

  2019cites this paper
• Title Initial Contact of Glioblastoma Cells with Existing Normal Brain Endothelial Cells Strengthen the Barrier Function via Fibroblast Growth Factor 2 Secretion : A New In Vitro Blood ‒ Brain Barrier Model

  2019cites this paper
• Mind the Gaps: Ontogeny of Human Brain P-gp and Its Impact on Drug Toxicity

  2019cites this paper
• The need for mathematical modelling of spatial drug distribution within the brain

  2019cites this paper
• Treatment of HIV associated neurocognitive disorders

  2018cites this paper
• Barriers to Effective Drug Treatment for Brain Metastases: A Multifactorial Problem in the Delivery of Precision Medicine

  2018cites this paper
• The biological significance of brain barrier mechanisms

  2018cites this paper
• A definite measure of occupancy exposures, seeking with non-radiolabeled in vivo 5-HT2A receptor occupancy and in vitro free fractions

  2018cites this paper
• Improving the Prediction of Local Drug Distribution Profiles in the Brain with a New 2D Mathematical Model

  2018cites this paper
• Bundling arrows: improving translational CNS drug development by integrated PK/PD-metabolomics

  2018cites this paper
• Delivery of immunoglobulin G antibodies to the rat nervous system following intranasal administration: Distribution, dose‐response, and mechanisms of delivery

  2018cites this paper
• Kps) of Basic Compounds in Subcutaneous Xenograft Mouse Models

  2018cites this paper
• Prediction of Tumor-to-Plasma Ratios of Basic Compounds in Subcutaneous Xenograft Mouse Models

  2017cites this paper
• Quantification of Bisoprolol and Metoprolol in Simultaneous Human Serum and Cerebrospinal Fluid Samples

  2017cites this paper
• Target Deconvolution Efforts on Wnt Pathway Screen Reveal Dual Modulation of Oxidative Phosphorylation and SERCA2

  2017cites this paper
• 1,3,5‐Trisubstituted Pyrazoles as Potent Negative Allosteric Modulators of the mGlu2/3 Receptors

  2017cites this paper
• MULTISPECIES EVALUATION OF ANTIRETROVIRAL DISPOSITION IN A PUTATIVE TISSUE RESERVOIR OF HIV: IMPLICATIONS FOR ERADICATION

  2017cites this paper
• Simultaneous in-vivo receptor occupancy assays for serotonin 1A, 2A, and dopamine 2 receptors with the use of non-radiolabelled tracers: Proposed method in screening antipsychotics.

  2017cites this paper
• Inhibiting Kinases in the CNS

  2017cites this paper
• Transependymal Cerebrospinal Fluid Flow: Opportunity for Drug Delivery?

  2017cites this paper
• Quantitative projection of human brain penetration of the H3 antagonist PF-03654746 by integrating rat-derived brain partitioning and PET receptor occupancy

  2017cites this paper
• Influence of peptide transporter 2 (PEPT2) on the distribution of cefadroxil in mouse brain: A microdialysis study

  2017cites this paper
• Reliability of In Vitro and In Vivo Methods for Predicting the Effect of P-Glycoprotein on the Delivery of Antidepressants to the Brain

  2016cites this paper
• Evaluation of the route dependency of the pharmacokinetics and neuro-pharmacokinetics of tramadol and its main metabolites in rats.

  2016cites this paper
• Measuring citalopram in blood and central nervous system: revealing a distribution pattern that differs from other antidepressants

  2016cites this paper
• Methods of Drug Delivery in Neurotrauma.

  2016cites this paper
• Chapter 24 – Lessons Learned: Clinical Trials and Other Interventions for Glioblastoma

  2016cites this paper
• The biological significance of brain barrier mechanisms: help or hindrance in drug delivery to the central nervous system?

  2016cites this paper
• Development of a permeability-limited model of the human brain and cerebrospinal fluid (CSF) to integrate known physiological and biological knowledge: Estimating time varying CSF drug concentrations and their variability using in vitro data.

  2016cites this paper
• Blood–brain barrier models: in vitro to in vivo translation in preclinical development of CNS-targeting biotherapeutics

  2015cites this paper
• Neural Network Ensemble Based QSAR Model for the BBB Challenge: A Review

  2015cites this paper
• Cerebrospinal fluid concentrations of vemurafenib in patients treated for brain metastatic BRAF-V600 mutated melanoma

  2015cites this paper
• Distribution pattern of mirtazapine and normirtazapine in blood and CSF

  2015cites this paper
• Designing Peripheral Drugs for Minimal Brain Exposure

  2015cites this paper
• Comparison of lacosamide concentrations in cerebrospinal fluid and serum in patients with epilepsy

  2015cites this paper
• Translational aspects of blood–brain barrier transport and central nervous system effects of drugs: From discovery to patients

  2015cites this paper
• Duloxetine enters the brain - But why is it not found in the cerebrospinal fluid.

  2015cites this paper
• Central Nervous System Penetration of Antiretroviral Drugs: Pharmacokinetic, Pharmacodynamic and Pharmacogenomic Considerations

  2015cites this paper
• Endogenous concentrations, pharmacokinetics, and selected pharmacodynamic effects of a single dose of exogenous GABA in horses.

  2015cites this paper
• Pharmacokinetics of CNS Penetration

  2015cites this paper
• Mass Spectrometry Imaging Reveals Heterogeneous Efavirenz Distribution within Putative HIV Reservoirs

  2015cites this paper
• PBPK Modeling Approach for Predictions of Human CNS Drug Brain Distribution

  2015cites this paper
• Quantitative determination of fentanyl in newborn pig plasma and cerebrospinal fluid samples by HPLC-MS/MS.

  2015cites this paper
• Kinetics of drug action in disease states: towards physiology-based pharmacodynamic (PBPD) models

  2015cites this paper
• Pharmacokinetic Concepts in Brain Drug Delivery

  2014cites this paper
• Restricting CNS penetration of drugs to minimise adverse events: role of drug transporters.

  2014cites this paper
• The nasal approach to delivering treatment for brain diseases: an anatomic, physiologic, and delivery technology overview.

  2014cites this paper
• Use of Cassette Dosing Approach to Examine the Effects of P-Glycoprotein on the Brain and Cerebrospinal Fluid Concentrations in Wild-Type and P-Glycoprotein Knockout Rats

  2014cites this paper
• Drug Discovery Methods for Studying Brain Drug Delivery and Distribution

  2014cites this paper
• Effect of protein binding on unbound atazanavir and darunavir cerebrospinal fluid concentrations

  2014cites this paper
• Blood-to-Brain Drug Delivery Using Nanocarriers

  2014cites this paper
• Engineering and pharmacology of blood-brain barrier-permeable bispecific antibodies.

  2014cites this paper
• Role of Microdialysis in Pharmacokinetics and Pharmacodynamics: Current Status and Future Directions

  2014cites this paper
• PKPD Aspects of Brain Drug Delivery in a Translational Perspective

  2014cites this paper
• Regulation of P-glycoprotein by Nuclear Receptors at the Blood-brain Barrier: Relevance to Human Immunodeficiency Virus-1 Pharmacotherapy

  2014cites this paper
• Kappa Opioid Receptor Agonists: New Targets In The Treatment Of Pain

  2014cites this paper
• Quantitative Investigation of the Brain-to-Cerebrospinal Fluid Unbound Drug Concentration Ratio under Steady-State Conditions in Rats Using a Pharmacokinetic Model and Scaling Factors for Active Efflux Transporters

  2014cites this paper
• Prediction of methotrexate CNS distribution in different species - influence of disease conditions.

  2014cites this paper
• Integrated Approach to Optimizing CNS Penetration in Drug Discovery: From the Old to the New Paradigm and Assessment of Drug–Transporter Interactions

  2014cites this paper
• Neuropharmacokinetics of two investigational compounds in rats: divergent temporal profiles in the brain and cerebrospinal fluid.

  2014cites this paper
• Microdialysis: A Real-Time Sampling Technique for More Effective Pharmacokinetic- Pharmacodynamic Studies in Drug Research and

  2014influential citation
• A novel platform for engineering blood‐brain barrier‐crossing bispecific biologics

  2014cites this paper
• Estimation of the unbound brain concentration of P-glycoprotein substrates or nonsubstrates by a serial cerebrospinal fluid sampling technique in rats.

  2014cites this paper